The article highlights several negative factors affecting XRAY's Q4 performance, including revenue loss from Byte, weak demand in the U.S. for equipment, and pressures in the implant market. These factors are likely to negatively impact XRAY's earnings report, leading to a potential short-term decline in stock price.